Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

COVID-19 Vaccination Might Induce Reversible Cerebral Vasoconstriction Syndrome Attacks: A Case Report

Research output: Contribution to journalJournal articlepeer-review

DOI

  1. Effect of KATP channel blocker glibenclamide on PACAP38-induced headache and hemodynamic

    Research output: Contribution to journalJournal articlepeer-review

  2. Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies

    Research output: Contribution to journalJournal articlepeer-review

  3. Blastic plasmacytoid dendritic cell neoplasm and cerebral toxoplasmosis: a case report

    Research output: Contribution to journalJournal articlepeer-review

  4. Arterial responses to infusion of glucagon-like peptide-1 in humans: A randomized trial study

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

A 30-year-old male diagnosed three years previously with reversible cerebral vasoconstriction syndrome (RCVS) presented to the department of neurology with an accumulation of attacks mimicking previous RCVS attacks and fulfilling the diagnostic criteria for RCVS after receiving the first Pfizer COVID-19 vaccine. The neurologic exam, blood samples, electrocardiogram (ECG), and computer tomography of the head (CTC) were normal. The patient was treated with the angiotensin 2 receptor antagonist, losartan, with a good response and was discharged with a prescription for losartan lasting until three days after the second Pfizer COVID-19 vaccine. No further RCVS attacks were reported. These findings indicate that the COVID-19 vaccine might induce RCVS attacks in susceptible individuals, and targeting the angiotensin 2 receptor could be a preventive option.

Original languageEnglish
Article number823
JournalVaccines
Volume10
Issue number5
ISSN2076-393X
DOIs
Publication statusPublished - 23 May 2022

    Research areas

  • corona virus, Pfizer, vaccination, headache

ID: 78297139